Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Gossamer Bio Q4 EPS $(0.59) Beats $(0.62) Estimate

Gossamer Bio (NASDAQ:GOSS) reported quarterly losses of $(0.59) per share which beat the analyst consensus estimate of $(0.62) by 4.84 percent. This is a 20.27 percent increase over losses of $(0.74) per share from the
byBenzinga Newsdesk
March 17, 2023
1 minute read
Total
0
Shares
0
0
0
0
0
0

Gossamer Bio (NASDAQ:GOSS) reported quarterly losses of $(0.59) per share which beat the analyst consensus estimate of $(0.62) by 4.84 percent. This is a 20.27 percent increase over losses of $(0.74) per share from the same period last year.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts
Read More

AG Mortgage Investment Trust Announces Series Of Corporate Governance Changes; T.J. Durkin As The Company’s CEO Effective October 1, Continue As President Of Board; David Roberts Will Resign As The Company’s Chairman And CEO

By Benzinga Newsdesk
September 22, 4:30 PM
T.J. Durkin, President of MITT, to Assume Role of Chief Executive Officer of MITT Lead Independent Director Debra Hess to Become Non-Executive Chair of MITT's Board of Directors Nicholas Smith, Chief Investment

MITT